Treatment outcome on 52 patients with 53 testicular germ cell tumors

Acta Urologica Japonica

Volumn 44, Issue 11, 1998, Pages 789-794

  Yokoyama, Masao ^a   Nemoto, Kaoru ^a   Kanemura, Mikio ^a   Kitahara, Ken ^a   Oda, Hiroyuki ^a   Murata, Hirokatsu ^a   Matsunaga, Yoshihiro ^a  

^a NONE

Author keywords

Testicular germ cell tumor; Treatment result; VAB 6 chemotherapy

Indexed keywords

BLEOMYCIN; DOXORUBICIN; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; SEMINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; GERMINOMA; HUMANS; MALE; MIDDLE AGED; ORCHIECTOMY; RADIOTHERAPY, ADJUVANT; SEMINOMA; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0032411394     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Einhorn LH : Treatment of testicular cancer. J Clin Oncol 8 : 1777-1781, 1990
2. Einhorn LH and Donohue JP : Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer Ann Intern Med 87 : 293-298, 1977
3. Vugrin D, Herr HW, Whitmore WF Jr, et al. : VAB-6 combination chemotherapy in disseminated cancer of testis. Ann Intern Med 95 : 59-61, 1981
4. Birch R, Wiliams SD, Cone A, et al. : Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4 : 400-407, 1986
5. The International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification : a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15 : 594-603, 1997
6. Thomas GM, Sturgeon JF, Alison R, et al. : A study of post-orchiectomy surveillance in stage I testicular seminoma. J Urol 142: 313-316, 1989
7. Warde P, Gospodarowicz MK, Panzarella T, et al. : Stage I testicular seminoma : results of adjuvant irradiation and surveillance. J Clin Oncol 13 : 2255-2262, 1995
8. Donohue JP, Foster RS, Rowland RG, et al. : Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144 : 287-291, 1990
9. Sesterhenn IA, Weiss RB, Mostofi FK, et al. : Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma : a report from the Testicular Cancer Intergroup Study. J Clin Oncol 10 : 69-78, 1992
10. Sogani PC, Perrotti M, Herr HW, et al. : Clinical stage I testis cancer : long-term outcome of patients on surveillance. J Urol 159 : 855-858, 1998
11. Klepp O, Olsson AM, Henrikson H, et al. : Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis : multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 8 : 509-518, 1990
12. Oliver RTD, Raja MA, Ong J, et al. : Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage I malignant teratoma on overall relapse rate of stage I cancer patients. J Urol 148 : 1453-1456, 1992
13. Studer UE, Fey MF, Calderoni A, et al. : Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. Eur Urol 23 : 444-449, 1993
14. Bosl GJ, Gluckman R, Geller NL, et al. : VAB-6 : An effective chemotherapy regimen for patients with germ cell tumors. J Clin Oncol 4 : 1493-1499, 1986
15. Mencel PJ, Motzer RJ, Mazumdar M, et al. : Advanced seminoma : treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 12 : 120-126, 1994
16. Droz JP, Kramer A and Rev A : Prognostic factors in metastatic disease. Semin Oncol 19 : 181-189, 1992
17. Williams SD, Birch R, Einhorn LH, et al. : Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316 : 1435-1440, 1987
18. Bosl GJ, Geller NL, Bajorin D, et al. : A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6 : 1231-1238, 1988
19. Culine S, Theodore C, Terrier-Lacombe MJ, et al. : Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles ol etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis ? the need for a randomized trial. J Urol 157 : 855-859, 1997
20. de Wit R, Stoter G, Kaye SB, et al. : Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma : a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 15 : 1837-1843, 1997
21. Broun ER, Nichols CR and Kneebone P : Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117 : 124-128, 1992
22. Siegert W, Beyer J and Strohscheer I : High-dose treatment with carboplatin, etoposide and ifosphamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer, a phase I/II study. J Clin Oncol 12 : 1223-1231, 1994
23. Broun ER, Nichols CR, Gize G, et al. : Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 79 : 1605-1610, 1997
24. Motzer RJ, Bajorin DF, Schwartz LH, et al. : Phase II trial of Paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 12 : 2277-2283, 1994
25. Akaza H, Togashi M, Nishino Y, et al. : Phase II study of cis-diammine (glycolato) platium, 254-S, in patients with advanced germ cell testicular cancer, prostatic cancer and transitional cell carcinoma of urinary tract. Cancer Chemother Pharmacol 31 : 187-192, 1992